Larry Jasinski - Rewalk Robotics CEO, Director
| RWLKDelisted Stock | USD 1.05 0.04 3.96% |
CEO
Mr. Larry Jasinski serves as Chief Executive Officer, Director of ReWalk Robotics Ltd. Mr. Jasinski has served as our Chief Executive Officer and as a member of our board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed nextgeneration treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporationrationration. Mr. Jasinski has served on the board of directors of Massachusetts Bay Lines since 2015 and of LeMaitre Vascular, Inc. since 2003 since 2012.
| Age | 57 |
| Tenure | 12 years |
| Professional Marks | MBA |
| Phone | 972 4 959 0123 |
| Web | https://www.rewalk.com |
Rewalk Robotics Management Efficiency
The company has return on total asset (ROA) of (0.1665) % which means that it has lost $0.1665 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3424) %, meaning that it created substantial loss on money invested by shareholders. Rewalk Robotics' management efficiency ratios could be used to measure how well Rewalk Robotics manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 897 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Rewalk Robotics has a current ratio of 21.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Rewalk Robotics until it has trouble settling it off, either with new capital or with free cash flow. So, Rewalk Robotics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rewalk Robotics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rewalk to invest in growth at high rates of return. When we think about Rewalk Robotics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | CEO Age | ||
| Stephen Neve | Bone Biologics Corp | 55 | |
| Michael Stewart | STRATA Skin Sciences | 67 | |
| Guy Ezekiel | BrainsWay | 45 | |
| Robert Spignesi | Rapid Micro Biosystems | 54 | |
| Leonard Liptak | ProSomnus Common Stock | 49 | |
| Nestor Jaramillo | Nuwellis | 67 | |
| Frank McCaney | STRATA Skin Sciences | N/A | |
| Andrew Simpson | Heart Test Laboratories | 54 | |
| Brian Murphy | NanoVibronix | 67 | |
| Steven Foster | Tenon Medical | 56 | |
| Gary Maharaj | SurModics | 61 | |
| Jeffrey Frelick | Bone Biologics Corp | 58 | |
| Dolev Rafaeli | STRATA Skin Sciences | 60 | |
| Joel Becker | Neuropace | 56 | |
| Nicholas Curtis | LENSAR Inc | 67 | |
Management Performance
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 |
Rewalk Robotics Leadership Team
Elected by the shareholders, the Rewalk Robotics' board of directors comprises two types of representatives: Rewalk Robotics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rewalk. The board's role is to monitor Rewalk Robotics' management team and ensure that shareholders' interests are well served. Rewalk Robotics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rewalk Robotics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, CEO Director | ||
| Jeff Dykan, Independent Chairman of the Board | ||
| Jay Kalish, Independent Director | ||
| John Hamilton, Vice President - Regulatory and Clinical | ||
| Miri Pariente, Global Director - Quality | ||
| Yohanan Engelhardt, Director | ||
| Charles Remsberg, Chief Officer | ||
| Glenn Muir, Independent Director | ||
| Wayne Weisman, Independent Director | ||
| Kevin Hershberger, CFO | ||
| Michael Lawless, Chief Officer | ||
| Deborah DiSanzo, Director | ||
| Lawrence Jasinski, CEO, Director | ||
| Ofir Koren, VP of RandD | ||
| Ning Cong, Independent Director | ||
| Ami Kraft, Ex CEO | ||
| Asaf Shinar, Independent Director | ||
| Judy Kula, Human Service | ||
| John Poduska, Independent Director Nominee | ||
| Ori Gon, CFO | ||
| Ori Schellas, Director of Operations | ||
| Aryeh Dan, Director | ||
| David Hexner, VP RD | ||
| Chunlin Han, Director | ||
| Kathleen ODonnell, Vice Development | ||
| Larry Jasinski, CEO, Director | ||
| Jodi Gricci, VP of Global Marketing | ||
| Hadar Ron, Independent Director | ||
| Peter Wehrly, Independent Director | ||
| Yasushi Ichiki, Director | ||
| Jeannine Lynch, Vice Strategy |
Rewalk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rewalk Robotics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (2.38) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 28.94 M | |||
| Shares Outstanding | 60.02 M | |||
| Shares Owned By Insiders | 1.96 % | |||
| Shares Owned By Institutions | 20.71 % | |||
| Number Of Shares Shorted | 1.36 M | |||
| Price To Earning | (0.77) X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Rewalk Stock
If you are still planning to invest in Rewalk Robotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rewalk Robotics' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |